Harnessing AI in medicines regulation: use of large language models (LLMs)
European Medicines Agency - European Union This workplan guides EMA and the EMRN in their use of AI, maximising the benefits while managing therisks, and facilitating information sharing …
Read the original at ema.europa.eu ↗
- Topics
- Regulation & PolicyChatbots & LLMsGovernment & Public Sector
- Mentions
- EuropeEuropean Union
- Tags
- AI Use Case
- Tracked via
- Google Alert “AI Risks”